- Marionville mayor ‘kind of agreed’ with Kansas City shooter’s views
- Rev. Al Sharpton’s Easter message: Politically ‘crucified’ Obama has risen again
- Supreme Court to weigh challenge to ban on campaign lies
- UNICEF launches ‘Mr. Poo’ mascot in India to curb public defecation
- Teen taking selfie by train: ‘Wow, that guy just kicked me in the head’
- Goodbye, Afghanistan — hello, Africa: Air Force to shift as U.S. exits Middle East
- Iran mulls ban on vasectomies, decrease on abortions to bolster population
- CNN op-ed claims right-wingers ‘more deadly than jihadists’
- Classes resume at high school rocked by stabbings
- ABC News accuses Center for Public Integrity of stealing Pulitzer-winning work
New S. African TB vaccine trials near completion
JOHANNESBURG (AP) - The first advanced clinical trials in South Africa for a tuberculosis vaccine are scheduled for completion by early next year, scientists said Tuesday.
South African researcher Dr. Hassan Mohomed said the trials will make medical history, even if the vaccine doesn’t work. He said the results will still help scientists understand the world epidemic and gather data that could hasten the eventual eradication of TB.
The government’s health department said Tuesday that South Africa has the second highest rate of TB infection in the world after the tiny southern African nation of Swaziland. TB is the biggest killer of HIV-positive South Africans, whose resistance to disease is lowered.
Mike Brennan, an adviser to the U.S.-based Aeras nonprofit TB research group, said the new worldwide blueprint for a plan of action followed “tremendous progress” already made in the past decade.
“Ten years ago no vaccine was in clinical trials,” he said Tuesday at the launch of a new global drive to find a vaccine.
The South African trials and work in other countries now mark “a rallying point for one of the world’s deadliest diseases” that includes strains resistant to conventional drugs, he said.
“It’s like building a house. We have the plans, we need builders to bring the finance and workers to bring the tools,” he said.
If trials over the next three years fail, scientists will learn where major gaps in their research lie.
“We are at a key time now when we have the hope of a new vaccine being developed over the next ten years,” he said.
That would relieve immense burdens on poor nations where TB and HIV/AIDS are prevalent.
Scientist Gavin Churchyard said projections a vaccine could be found by 2015 “are not going to happen.”
“We have got to think out of the box on new ways to find it,” he said.
David Mametja of the South African health department said South Africa recorded about 1,000 TB cases in every 100,000 members of the 50 million population, slightly behind Swaziland at about 1,300 per 100,000 people.
It recorded more than 7,000 virulent, resistant cases in 2010. Those cases took up to two years to treat at ten times the cost of common strains.
He said the government backed research for a vaccine but didn’t have “buckets and buckets” of money for it. It was looking for private funding to assist, possibly from mining companies whose miners worked in confined spaces and faced the highest risk of contracting the contagious illness.
TWT Video Picks
By returning to Christian roots, the nation can achieve greatness once again
- 'Culture of intimidation' seen in Nevada ranch standoff
- Rand and Ron Paul ride to the rescue for Bundy in Nevada standoff with feds
- Fuel-filled wings, ability to swarm: Pentagon offers glimpse at future of drone fleet
- WEBER: Obamacare cuts home healthcare for millions of seniors
- UNICEF launches 'Mr. Poo' mascot in India to curb public defecation
- CARSON: Recovering Tocqueville's vision of American exceptionalism
- Nevada Bundy ranch standoff could leave dirt on Harry Reid reputation
- CNN op-ed claims right-wingers 'more deadly than jihadists'
- U.S. Navy to turn seawater into jet fuel
- GOP writes legislation to deny Attorney General Eric Holder his salary
Celebrity deaths in 2014
Top 10 handguns in the U.S.